Chlamydia pneumoniae–specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms

References

• Archelos JJ, Hartung HP (2000). Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci 23:317–327.
   PubMed Web of Science ®Google Scholar
• Bagos PG, Nikolopoulos G, Ioannidis A (2006). Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 12:397-411.
   PubMed Web of Science ®Google Scholar
• Balin BJ, Gérard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP (1998). Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187:23-42.
   PubMed Web of Science ®Google Scholar
• Casetta I, Granieri E (2000). Clinical infections and multiple sclerosis: contribution from analytical epidemiology. J NeuroVirol 6(Suppl 2): S147-S151.
   Google Scholar
• Chapman MD, Thompson EJ, Candler PM, Dale RC, Church AJ, Giovannoni G (2007). Quantitative demonstration of intrathecal synthesis of high affinity immunoglobulin G in herpes simplex encephalitis using affinity-mediated immunoblotting. J Neuroimmunol 185:130-135.
   Google Scholar
• Conrad AJ, Chiang EY, Andeen LE, Avolio C, Walker SM, Baumhefner RW, Tourtellotte WW (1994). Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J Neuroimmunol 54:99-108.
   Google Scholar
• Contini C, Cultrera R, Seraceni S, Castellazzi M, Granieri E, Fainardi E (2004). Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis. Mult Scler 10:360-369.
   PubMed Web of Science ®Google Scholar
• Contini C, Fainardi E, Seraceni S, Granieri E, Castellazzi M, Cultrera R (2003). Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-associated dementia complex. Preliminary results. J Neuroimmunol 136:172-177.
   Google Scholar
• Contini C, Seraceni S, Castellazzi M, Granieri E, Fainardi E (2008). Chlamydophila pneumoniae DNA and mRNA transcript levels in peripheral blood mononuclear cells and cerebrospinal fluid of patients with multiple sclerosis. Neurosci Res 62:58-61.
   Google Scholar
• Danesh J, Collins R, Peto R (1997). Chronic infections and coronary heart disease: is there a link? Lancet 350: 430-436.
   PubMed Web of Science ®Google Scholar
• Derfuss T, Gürkov R, Bergh FT, Goebels N, Hartmann M, Barz C, Wilske B, Autenrieth I, Wick M, Hohlfeld R, Meinl E (2001). Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 124:1325-1335.
   PubMed Web of Science ®Google Scholar
• Dong-Si T, Weber J, Liu YB, Buhmann C, Bauer H, Bendl C, Schnitzler P, Grond-Ginsbach C, Grau, AJ (2004). Increased prevalence and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis. J Neurol 251:542-547.
   Google Scholar
• Dörries R, Kaiser R, ter Meulen V (1989). Human immunodeficiency virus infection: affinity-mediated immunoblot detects intrathecal synthesis of oligoclonal IgG specific for individual viral protein. AIDS Res Hum Retroviruses 5:303-310.
   Google Scholar
• Dreses-Werringloer U, Bhuiyan M, Zhao Y, Gérard HC, Whittum-Hudson JA, Hudson AP (2009). Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset alzheimer brain. Int J Med Microbiol 299:187-201.
   Google Scholar
• Fainardi E, Contini C, Benassi N, Bedetti A, Castellazzi M, Vaghi L, Govoni V, Paolino, E, Balboni P, Granieri E (2001). Assessment of HIV intrathecal humoral immune response in AIDS-related neurological disorders. J Neuroimmunol 119:278-86.
   Google Scholar
• Fainardi E, Castellazzi M, Casetta I, Cultrera R, Vaghi L, Granieri E, Contini C (2004). Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms. J Neurol Sci 217:181-188.
   PubMed Web of Science ®Google Scholar
• Fainardi E, Castellazzi M, Saraceni S, Granieri E, Contini C (2008). Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr Neurovasc Res 5:60-70.
   PubMed Web of Science ®Google Scholar
• Franciotta D, Avolio C, Capello E, Lolli F, AINI participating members (2005a). Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination. J Neurol Sci 237:5-11.
   PubMedGoogle Scholar
• Franciotta D, Cardini E, Bergamaschi R, Grimaldi LM, Androni L, Cosi V (2005b). Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurological diseases. Acta Neurol Scand 112:238-241.
   Google Scholar
• Gérard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH 2nd, Bordayo EZ, Whittum-Hudson JA, Hudson AP (2006). Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol 48:355-366.
   PubMedGoogle Scholar
• Gilden DH (2005). Infectious causes of multiple sclerosis. Lancet Neurol 4:195-202.
   PubMed Web of Science ®Google Scholar
• Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP (1995). Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 92:3397-3400.
   PubMed Web of Science ®Google Scholar
• Hauser SL, Oksenberg JR (2006). The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52:61-76.
   PubMed Web of Science ®Google Scholar
• Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DPE, Moseley IF, Rudge P, McDonald WI (1990). Breakdown of blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 113:1477-1489.
   PubMed Web of Science ®Google Scholar
• Krametter D, Niederwieser G, Berghold A, Birnbaum G, Strasser-Fuchs S, Hartung HP, Archelos JJ (2001). Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler 7:13-18.
   PubMed Web of Science ®Google Scholar
• Krüll M, Kramp J, Petrov T, Klucken AC, Hocke AC, Walter C, Schmeck B, Seybold J, Maass M, Ludwig S, Kuipers JG, Suttorp N, Hippenstiel S (2004). Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells. Infect Immun 72:6615-6621.
   Google Scholar
• Kurtzke JF (1983). Rating neurological impairment in multiple sclerosis: an expanded disability scale (EDSS). Neurology 33:1444-1452.
   PubMed Web of Science ®Google Scholar
• Lipton HL, Liang Z, Hertzler S, Son K-N (2007). A specific viral cause of multiple sclerosis: one virus, one disease. Ann Neurol 61:514-523.
   PubMedGoogle Scholar
• Lublin DF, Reingold SC 1996. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46: 907-911.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121-127.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Clark AP, Sullivan EsD, Miller RDRD, Summersgill JT (2004). Detailed protocol for purification of Chlamydia pneumoniae elementary bodies. J Clin Microbiol 42:3288-3290.
   Google Scholar
• Pachner AR, Li L, Narayan K (2007). Intrathecal antibody production in an animal model of multiple sclerosis. J Neuroimmunol 185:57-63.
   Google Scholar
• Poser CM, Paty DW, Scheimberger L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983). New diagnostic criteria for MS: guidelines for research protocols. Ann Neurol 13:227-231.
   PubMed Web of Science ®Google Scholar
• Reiber H, Lange P (1991). Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37:1153-1160.
   PubMed Web of Science ®Google Scholar
• Reiber H, Ungefehr S, Jacobi C (1998). The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4:111-117.
   PubMed Web of Science ®Google Scholar
• Rostasy K, Reiber H, Pohl D, Lange P, Ohlenbusch A, Eiffert H, Maass M, Hanefeld F (2003). Chlamydia pneumoniae in children with MS. Frequency and quantity of intrathecal antibodies. Neurology 61:125-128.
   Google Scholar
• Salden HJM, Bas BM, Hermas JT, Janson PC (1988). Analytical performance of the three commercially available nephelometers compared quantifying protein in serum and cerebrospinal fluid. Clin Chem 34:1594-1596.
   Google Scholar
• Smith-Jensen T, Burgoon MP, Anthony J, Kraus H, Gilden DH, Owens GP (2000). Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology 54:1227-1232.
   PubMed Web of Science ®Google Scholar
• Sommer K, Njau F, Wittkop U, Thalmann J, Bartling G, Wagner A, Klos A (2009). Identification of high- and low-virulent strains of Chlamydia pneumoniae by their characterization in a mouse pneumonia model. FEMS Immunol Med Microbiol 55:206-214.
   Google Scholar
• Sriram S, Stratton CW, Yao SY, Tharp A, Ding L, Bannan JD, Mitchell WM (1999). Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 46:6-14.
   PubMed Web of Science ®Google Scholar
• Tibbling G, Link H, Ohman S (1977). Principles of albumin and IgG analyses in neurological disorders: I. Establishment of reference value. Scand J Clin Lab Invest; 37:385-390.
   PubMed Web of Science ®Google Scholar
• Thompson EJ (2004). Quality versus quantity: which is better for cerebrospinal fluid IgG? Clin Chem 50:1721-1722.
   Google Scholar
• Yao SY, Stratton CW, Mitchell WM, Sriram S (2001). CSF oligoclonal bands in MS include antibodies against Chlamydiophila antigens. Neurology 56:1168-1176.
   Google Scholar